Related Experiment Video
Updated: Feb 2, 2026

Author Spotlight: Advancing Diabetes Research with Static Exercise Training in Mice
Published on: March 29, 2024
Changes in Splicing Machinery Components Influence, Precede, and Early Predict the Development of Type 2 Diabetes:
Manuel D Gahete1, Mercedes Del Rio-Moreno1, Antonio Camargo2
1Maimonides Institute for Biomedical Research of Cordoba (IMIBIC), Córdoba, Spain.; Universidad de Córdoba, Córdoba, Spain.; Reina Sofia University Hospital, Córdoba, Spain.; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Córdoba, Spain.
Background:
Type-2 diabetes mellitus (T2DM) is a major health problem with increasing incidence, which severely impacts cardiovascular disease. Because T2DM is associated with altered gene expression and aberrant splicing, we hypothesized that dysregulations in splicing machinery could precede, contribute to, and predict T2DM development.
Methods:
A cohort of patients with cardiovascular disease (CORDIOPREV study) and without T2DM at baseline (at the inclusion of the study) was used (n = 215). We determined the expression of selected splicing machinery components in fasting and 4 h-postprandial peripheral blood mononuclear cells (PBMCs, obtained at baseline) from all the patients who developed T2DM during 5-years of follow-up (n = 107 incident-T2DM cases) and 108 randomly selected non-T2DM patients (controls). Serum from incident-T2DM and control patients was used to analyze in vitro the modulation of splicing machinery expression in control PBMCs from an independent cohort of healthy subjects.
Findings:
Expression of key splicing machinery components (e.g. RNU2, RNU4 or RNU12) from fasting and 4 h-postprandial PBMCs of incident-T2DM patients was markedly altered compared to non-T2DM controls. Moreover, in vitro treatment of healthy individuals PBMCs with serum from incident-T2DM patients (compared to non-T2DM controls) reduced the expression of splicing machinery elements found down-regulated in incident-T2DM patients PBMCs. Finally, fasting/postprandial levels of several splicing machinery components in the PBMCs of CORDIOPREV patients were associated to higher risk of T2DM (Odds Ratio > 4) and could accurately predict (AUC > 0.85) T2DM development.
Interpretation:
Our results reveal the existence of splicing machinery alterations that precede and predict T2DM development in patients with cardiovascular disease. FUND: ISCIII, MINECO, CIBERObn.
Insights
Alterations in splicing machinery components precede and predict Type-2 diabetes mellitus (T2DM) development in cardiovascular disease patients. These changes in gene expression offer a new risk assessment tool for T2DM.
Area of Science:
- Molecular biology
- Genetics
- Endocrinology
Background:
- Type-2 diabetes mellitus (T2DM) is a growing global health concern, significantly increasing cardiovascular disease risk.
- Aberrant gene expression and splicing are linked to T2DM, suggesting a role for splicing machinery dysregulation.
Purpose of the Study:
- To investigate if splicing machinery dysregulations precede, contribute to, and predict T2DM development.
- To analyze splicing machinery component expression in patients with cardiovascular disease.
Main Methods:
- Studied 215 patients with cardiovascular disease, assessing splicing machinery component expression in peripheral blood mononuclear cells (PBMCs).
- Compared baseline fasting and postprandial PBMCs from patients who developed T2DM (n=107) versus those who did not (n=108) over 5 years.
- In vitro analysis of PBMC splicing machinery expression using serum from T2DM patients.
Main Results:
- Markedly altered expression of key splicing machinery components (e.g., RNU2, RNU4, RNU12) in incident T2DM patients' PBMCs.
- Serum from incident T2DM patients reduced splicing machinery component expression in healthy PBMCs.
- Fasting/postprandial splicing machinery component levels in PBMCs predicted T2DM risk (OR > 4) and development (AUC > 0.85).
Conclusions:
- Splicing machinery alterations are present before and can predict T2DM development in cardiovascular disease patients.
- These findings highlight splicing machinery as a potential biomarker for T2DM risk assessment.
Related Concept Videos
Diabetes Mellitus: Type 2 and Gestational
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
RNA Splicing
Predicting Products: SN1 vs. SN2
With increased substitution on the alkyl halide,...
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...

